Renew Biotechnologies
Steven Abbott is an accomplished professional with extensive experience in the biotechnology and genomics sectors. Currently serving as Chief Operating Officer at Renew Biotechnologies since July 2024, Steven has previously held key leadership positions, including Vice President of Lab Operations at Flagship Biosciences, Inc., and various roles at Q² Solutions, where responsibilities included oversight of global Next Generation Sequencing (NGS) operations across multiple regions, managing personnel and budgets, and developing global vendor relationships. Steven also has a strong background in research, having contributed to the development of innovative sequencing methods and systems at several organizations, including Expression Analysis and Duke University. Steven holds a Bachelor of Science degree in Biological Sciences from Virginia Tech.
This person is not in any teams
Renew Biotechnologies
Renew BioTechnologies is a dynamic holding company dedicated to exploring and embracing groundbreaking biotechnologies and intellectual property. With a remarkable knack for capturing market share, Renew excels in leveraging its cutting-edge technologies and spearheads innovation in the field. Renowned for its strategic alliances and sponsored research agreements with leading universities, Renew consistently enjoys a robust pipeline of exciting new biotech projects, propelling the frontiers of scientific progress.